Inhibition of cell proliferation and induction of apoptosis in K562 human leukemia cells by the derivative (3-NpC) from dihydro-pyranochromenes family

被引：22

作者：

Rahimi, Roghayeh ^{[1
]}

Mahdavi, Majid ^{[1
]}

Pejman, Sina ^{[1
]}

Zare, Payman ^{[2
]}

Balalaei, Saeed ^{[3
]}

机构：

[1] Univ Tabriz, Fac Nat Sci, Dept Biol, Tabriz, Iran

[2] Univ Tabriz, Fac Vet Med, Dept Pathobiol, Tabriz, Iran

[3] KN Toosi Univ Tech, Fac Sci, Dept Chem, Tehran, Iran

来源：

ACTA BIOCHIMICA POLONICA | 2015年 / 62卷 / 01期

关键词：

apoptosis; chronic myeloid leukaemia; dihydro-pyranochromenes; K562; cells; ONE-POT SYNTHESIS; CYTOTOXIC ACTIVITY; 4-ARYL-4H-CHROMENES; ACTIVATION; ASSAY; DIFFERENTIATION; DISCOVERY; BIOLOGY; SERIES;

D O I：

10.18388/abp.2014_825

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Leukemia is a particular type of cancer characterized by the failure of cell death or disability in differentiation of hematopoietic cells. Chronic myelogenus leukemia (CML) is the most studied kind of this cancer. In this study, anti-cancer effect of dihydro-pyranochromenes derivatives were investigated in the human leukemia K562 cells. These compounds were found to be active cell proliferation inhibitors using MU assay. Among these compounds, 3-NpC was determined as stronger compound with IC50 value of 100 +/- 3.1 mu M and was chosen for further studies. Induction of apoptosis was analyzed by AO/EtBr staining, DNA fragmentation assay, Annexin V/PI double staining and cell cycle analysis. Furthermore, Western Blot analysis showed that treatment of the cells with 3-NpC led to up-regulation and activation of caspase-3. The results of this investigation clearly indicated that dihydro-pyranochromenes derivatives induce apoptosis in the K562 cell line. This information signalizes also that these compounds may prepare a new therapeutic approach for the treatment of leukemia.

引用

页码：83 / 88

页数：6

共 27 条

[1] Novel and efficient catalysts for the one-pot synthesis of 3,4-dihydropyrano[c]chromene derivatives in aqueous media [J].